Written Educational Information and Phone Calls in Increasing Follow-Up Care in Hispanic Women With Abnormal Pap Smears
NCT ID: NCT00483288
Last Updated: 2017-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
238 participants
INTERVENTIONAL
2005-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying how well written educational information and phone calls work in increasing follow-up care in Hispanic women with abnormal Pap smears.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214
HPV Self-sampling for Underscreened Latinas
NCT06439706
HPV Self-Test Intervention in Ohio Appalachia
NCT02460237
Patient Compliance to Self-collection for Detection of HPV-DNA
NCT02431520
Project Self in Improving Cervical Cancer Screening Rates in Hispanic and African American Women
NCT04614155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Determine the reasons for nonadherence to follow-up in Hispanic women with abnormal Pap smear findings.
* Assess the effect of written educational information and phone calls on follow-up rate in these patients.
OUTLINE: This is a pilot, cross-sectional, controlled, multicenter study. Patients are sequentially assigned to 1 of 3 intervention groups.
* Group 1 (control): Patients complete a standardized Spanish survey questionnaire, assessing their demographic information, knowledge, attitudes, behaviors, experiences with cervical screening, past medical history, and prior treatment, either in person (for those who kept their colposcopy appointment) or over the telephone (for those who did not keep their colposcopy appointment). Additional questions are added for patients who did not keep their colposcopy appointment to test for differences and to learn the reasons for not keeping their appointment.
* Group 2 (written educational information): Patients receive notification of their colposcopy appointment and an educational letter about Pap smears, cervical cancer risk, and the purpose and procedure of colposcopy. They complete the standardized Spanish survey questionnaire as in group 1.
* Group 3 (phone call): Patients receive notification of their colposcopy appointment and a personal telephone call educating them about Pap smears, cervical cancer risk, and the purpose and procedure of colposcopy. They complete the standardized Spanish survey questionnaire as in group 1.
All patients are asked to agree to submit residual Pap smear fluid to the Comprehensive Cancer Center of Wake Forest University tumor bank, and be included in a tracking system to insure future follow-up communications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
HEALTH_SERVICES_RESEARCH
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
educational intervention
questionnaire administration
study of socioeconomic and demographic variables
survey administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Abnormal Pap smear findings indicating the need for further treatment at the colposcopy clinic
* Scheduled for colposcopy at the Comprehensive Cancer Center of Wake Forest University
* No history of invasive cervical cancer
PATIENT CHARACTERISTICS:
* Must be of Hispanic background, including any of the following:
* Hispanic
* Latino
* Chicano
* Mexican American
* Puerto Rican
* Cuban American
PRIOR CONCURRENT THERAPY:
* Not specified
18 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte E. Miller, MD
Role: STUDY_CHAIR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wake Forest University Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000547179
Identifier Type: REGISTRY
Identifier Source: secondary_id
CCCWFU-BG04-578
Identifier Type: -
Identifier Source: secondary_id
CCCWFU-30104B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.